Quarterly report pursuant to Section 13 or 15(d)
Cover
Cover Page
Financial Statements
Consolidated Balance Sheets
Consolidated Balance Sheets (Parenthetical)
Consolidated Statements of Operations
Consolidated Statements of Comprehensive Loss
Consolidated Statements of Stockholders' Equity
Consolidated Statements of Cash Flows
Notes to Financial Statements
Organization and Description of Business
Summary of Significant Accounting Policies
Marketable Securities
Fair Value Measurements
Accrued Liabilities
Net Loss Per Share of Common Stock
Commitments and Contingencies
Capital Structure
Stock Warrants
Stock Option and Incentive Plans
Accounting Policies
Summary of Significant Accounting Policies (Policies)
Notes Tables
Fair Value Measurements (Tables)
Accrued Liabilities (Tables)
Net Loss Per Share of Common Stock (Tables)
Commitments and Contingencies (Tables)
Capital Structure (Tables)
Stock Warrants (Tables)
Stock Option and Incentive Plans (Tables)
Notes Details
Organization and Description of Business - Additional Information (Detail)
Summary of Significant Accounting Policies - Additional Information (Detail)
Marketable Securities - Schedule of Marketable Securities (Detail)
Marketable Securities - Additional Information (Detail)
Fair Value Measurements - Information about Company's Financial Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail)
Fair Value Measurements - Assumption Used to Determine Fair Value of Warrant Liability (Detail)
Fair Value Measurements - Reconciliation of Company's Financial Liabilities Measured at Fair Value on Recurring Basis Using Significant Unobservable Inputs (Level 3) (Detail)
Accrued Liabilities - Summary of Accrued Liabilities (Detail)
Net Loss Per Share of Common Stock - Schedule of Computation of Basic and Diluted Loss Per Share for Common Stockholders (Detail)
Net Loss Per Share of Common Stock - Schedule of Antidilutive Securities Excluded from Computation of Diluted Weighted Average Shares Outstanding (Detail)
Commitments and Contingencies - Additional Information (Detail)
Commitments and Contingencies - Schedule of Classification of Lease Liabilities (Detail)
Commitments and Contingencies - Maturities Of Operating Lease Liabilities (Detail)
Commitments and Contingencies - Lease Cost (Detail)
Capital Structure - Additional Information (Detail)
Capital Structure - Summary of Common Stock Reserved for Future Issuance (Detail)
Stock Warrants - Schedule of Warrants Outstanding (Detail)
Stock Option and Incentive Plans - Additional Information (Detail)
Stock Option and Incentive Plans - Summary of Stock Option Activity (Detail)
Stock Option and Incentive Plans - Assumptions to Compute Fair Value of Stock Option Grants (Detail)
Accrued Liabilities (Tables)
v3.22.1
Accrued Liabilities (Tables)
3 Months Ended
Mar. 31, 2022
Payables and Accruals [Abstract]
Summary of Accrued Liabilities
Accrued liabilities consist of the following as of March 31, 2022 and December 31, 2021 (in thousands):
March 31,
2022
December 31,
2021
Accrued research and development service fees
$
5,962
$
5,641
Accrued professional fees
936
819
Accrued compensation costs
599
2,215
Accrued facilities operation expenses
111
307
Other accrued expenses
28
146
Total accrued liabilities
$
7,636
$
9,128
X
- References
No definition available.
+ Details
Name:
us-gaap_PayablesAndAccrualsAbstract
Namespace Prefix:
us-gaap_
Data Type:
xbrli:stringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Tabular disclosure of the components of accrued liabilities.
+ References
No definition available.
+ Details
Name:
us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock
Namespace Prefix:
us-gaap_
Data Type:
dtr-types:textBlockItemType
Balance Type:
na
Period Type:
duration